Trial intelligence / Profile preview

Aleve vs Tylenol for menstrual cramp pain in primary dysmenorrhea

2017-005031-17Phase 4

Sponsor
Bayer
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Aprol and acetaminophen in primary dysmenorrhea (PD) and dysmenorrhea (2 arms), sponsored by Bayer. Primary endpoint: Sum of Total Pain Relief over 0-12 hours (TOTPAR0-12).

02

Drugs

Aprolacetaminophen
03

Conditions

primary dysmenorrhea (PD)dysmenorrhea

Beyond the preview

Go deeper on 2017-005031-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-005031-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call